Nguyen KA, McLemore LE, Ke Y, DePledge LN, Smith LP, Bian L, Aleman JD, Debretsion D, Wong E, Manning N, Wang XJ, Young CD. Activation of PI3K and deletion of p53 in keratin 15-expressing mouse mammary cells induces tumor heterogeneity and plasticity modeling metaplastic breast cancer. J Pathol. 2025 Oct;267(2):213-224. PubMed PMID: 40804766
Chen DY, Ludwigson A, Higgins MG, Leslie SE, Durden J, Lin CT, Miles RC, Taft N, Wolverton D, McLemore L, Baurle E, Tevis SE. MedEd: An innovative approach to enhance patient comprehension and interpretation of a sample mammography report. Am J Surg. 2025 Dec;250:116643. PubMed PMID: 41086567
Bheemireddy S, Leslie SE, Durden JA, Burnet G, Aryanpour Z, Fong A, Higgins MG, Greenseid S, McLemore L, Li G, Miles R, Taft N, Tevis S. The Use of ChatGPT-4.0 to Simplify Breast Pathology Reports: A Study on Readability and Accuracy. Ann Surg Oncol. 2025 Oct;32(11):8400-8408. PubMed PMID: 40690168
Vemuru S, Huang J, Colborn K, Yoon Y, Huynh V, Leonard L, Ahrendt G, Christian N, Afghahi A, McLemore L, Sams S, Tevis S. Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy. Breast Cancer Res Treat. 2023 Jul;200(2):247-256. doi: 10.1007/s10549-023-06978-0. Epub 2023 May 26. PMID: 37233961.
McLemore L, Achrati SM, Berg M, Henn P, Rosser JA, Samedi V, Xu C, Westbrook LM. Pathology-Specific Residency Application Scoring Metric: An Attempt to Decrease Bias in Applicant Selection. United States and Canadian Academy of Pathology Virtual Annual Meeting. March 2021. ACCEPTED.
McLemore LE, Albarracin CT, Gruschkus SK, Bassett RL Jr, Wu Y, Dhamne S, Yim I, Lin K, Bedrosian I, Sneige N, Chen H. HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines. Breast Cancer Res Treat. 2021 May;187(1):95-104. PubMed PMID: 33813685